To: Board of Supervisors
From: Dr. Ori Tzvieli, Interim Health Services Director
Report Title: Contract #76-904 with Gold Stallion, Inc. (dba Mariner Advanced Pharmacy)
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Interim Health Services Director, or designee, to execute on behalf of the County, Contract #76-904 with Gold Stallion, Inc. (dba Mariner Advanced Pharmacy), a corporation, in an amount not to exceed $180,000, to provide chemotherapy compounding services for the Contra Costa Regional Medical Center (CCRMC) Chemotherapy Infusion Pharmacy, for the period March 1, 2025 through February 28, 2026.
FISCAL IMPACT:
Approval of this Contract will result in annual expenditures of up to $180,000 and will be funded as budgeted by the department, 100% by Hospital Enterprise Fund I revenues.
BACKGROUND:
The County has an obligation to provide certain specialized chemotherapy compounding services for the CCRMC Chemotherapy Infusion Pharmacy. This Contractor provides sterile compounded hazardous chemotherapy agents to CCRMC patients in infusion in case of unforeseen closures of the CCRMC Infusion Pharmacy for possible maintenance or emergency reasons. This Contractor has been providing these chemotherapy compounding services for the County on a purchase order. Contractor will continue to foster a deep understanding of the CCRMC organizations mission, values, and long-term objectives, under this service Contract. This Contract is entered into under and subject to the following legal authorities: California Government Code §§ 26227 and 31000; Health and Safety Code § 1451. Health Services Personnel approved this Contract to ensure no conflicts with labor relations. Contractor currently cooperates with and participates in CCRMC’s Quality Assurance Program which consists of quality improvement activities such as providing a summary of quality assurance data including temperature monitoring, quantitative and sterility testing results and other relevant data. This Contractor was approved by the Public Works Department’s Purchasing Division on January 3, 2025.
Under new Contract #76-904, Contractor will provide chemotherapy compounding services for the CCRMC Chemotherapy Infusion Pharmacy through February 28, 2026. This Contract includes a mutual indemnification provision, which requires each party to indemnify , defend, and hold the other party harmless for claims arising due to the negligence of intentional acts or omissions of that indemnifying party. This Contract also includes County’s standard Health Insurance Portability and Accountability Act (HIPAA) of 1996 Business Associate Addendum.
CONSEQUENCE OF NEGATIVE ACTION:
If this Contract is not approved, certain specialized chemotherapy compounding services for CCRMC patients will not be provided and may risk County not being in compliance with the California State Board of Pharmacy.